Cardioembolic strokes occur when blood clots form in the heart—often due to atrial fibrillation or other structural changes—and travel to the brain, blocking blood flow. These strokes tend to be more severe and recurrent, making early detection and prevention critical.

The Cardioembolic Stroke-Dx service interprets CARMD-Dx biomarker results to identify molecular signals of atrial remodeling, clotting risk, and vascular stress associated with cardioembolic stroke. By detecting risk early, this service supports proactive intervention strategies that can save lives.

Why This Test Matters

Key Benefits

Standard scans can miss early cardiac and vascular changes. Cardioembolic Stroke-Dx detects these disruptions at the molecular level so patients and clinicians can act early.

Early Stroke Risk Detection

Identifies molecular patterns linked to clot formation and embolic events.

Actionable Data

Provides evidence for anticoagulation and other preventive therapies.

Integrated Cardiac & Vascular Insight

Links atrial remodeling, coagulation, and vascular stress.

Progress Monitoring

Tracks biomarker changes over time to measure treatment effectiveness.

Physician-Ready Report Included

Results in
10-14 days

Reliable Results You Can Trust

Biomarkers Assessed

The Cardioembolic Stroke-Dx panel measures a targeted range of biomarkers to detect subtle cardiac, vascular, and coagulation changes:

  • Coagulation and clotting factors (D-dimer, fibrinogen, thrombin markers)

  • Atrial remodeling proteins (natriuretic peptides, ANP/BNP)

  • Endothelial dysfunction markers (VCAM-1, ICAM-1, selectins)

  • Inflammatory cytokines (IL-6, TNF-α, CRP)

  • Neurovascular stress markers linked to ischemia

Download a Sample Report

How It Works

Process

From registration to results, the process is simple, secure, and stress-free. One blood draw gives you answers that imaging can’t.

01

Order & Registration

Patient registers through Persona Biomed’s secure portal.

02

Sample Collection

Blood draw at an approved site or mobile phlebotomy.

03

Laboratory Analysis

High-sensitivity biomarker assays measure coagulation, atrial stress, and vascular health.

04

Results Delivery

Comprehensive report delivered in the patient portal, with physician-ready data and AI-supported summaries for patients.

Who Should Consider This Test

who is this for

This test is intended for individuals who may be at risk, are experiencing related symptoms, or wish to take a proactive approach to their health, such as:

  • Patients with atrial fibrillation or other arrhythmias.

  • Individuals with a history of transient ischemic attack (TIA) or stroke.

  • Patients with structural heart disease or valvular disorders.

  • High-risk populations (hypertension, diabetes, obesity, advanced age).

Register Now for
Cardioembolic Stroke-Dx

Register now for Cardioembolic Stroke-Dx to detect hidden risks for embolic stroke and take steps toward prevention and protection.

Register now